[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Medical Journalism::
::
Search in website

Advanced Search
..
INDEX









 
..
:: Search published articles ::
Showing 2 results for Laghousi

Mahin Ahangar Oskouee, Arezou Azadi, Javid Sadeghi, Farzad Bahari, Delara Laghousi,
Volume 15, Issue 1 (6-2021)
Abstract

Background and Aims: Hepatitis B is a viral infection that attacks the liver and can cause both acute and chronic disease. Thus, the present study focused on antibody titer among HBV-vaccinated medical students in order to evaluate the efficacy of Hepatitis B vaccine and the associated factors.
Materials and Methods: In this cross-sectional study, 184 medical students were enrolled. Blood samples were taken from the participants in order to detection of antibody against Hepatitis BsAg by ELISA. Data analysis was done by Chi-square and Fisher’s exact tests.
Results: According to the obtained results, 1.1% of the students had a negative titer, while another 53.8 % were in the borderline situation; whereas 45.1% produced a positive titer. Furthermore, the results revealed that there was no statistically significant difference between Hepatitis B antibody titer values and variables such as gender (P<0/05).
Conclusion: By considering the fact that medical students are at greater risk of HBV infection, it is necessary to schedule the determination of serum anti-HBs titer to improve the immunization programs and to decrease the risk of infection before internship program. Re-vaccination (booster shot) is also necessary for people with low titers anti- HBs or loss antibody and controls their antibody titers, and also in who are considered as high-risk group in the society.

Delara Laghousi, Hossein Bannazadeh Baghi, Vahdat Poortahmasebi, Arezou Azadi, Robab Nomani, Muslim Ghasemi Nia, Javid Sadeghi, Mahin Ahangar Oskouee,
Volume 15, Issue 2 (12-2021)
Abstract

Background and Aims: The exact protective antibody to the SARS- CoV-2 is still unknown. This study aimed to compare molecular and serological testing for the diagnosis of Covid-19.
Materials and Methods: In this study, a total of 100 participants, 50 patients with confirmed SARS-CoV-2 infection using real-time reverse transcriptase PCR (RT-PCR) and 50 controls with negative RT-PCR test, were enrolled. The serum level of IgM and IgG antibodies against nucleocapsid antigens of SARS-CoV-2 were tested using the enzyme-linked immunosorbent assays (ELISAs) and also antibodies were tested again after four months in the case group. This study was carried out in the Asadabadei clinic between April and June 2020.
Results: The Seroconversion rates of IgM in the case and control groups were 14% and 4%, respectively, but the differences were not statistically significant (P =0.134). In the case group, the Seroconversion rate of IgG was significantly higher than the control group (44% vs. 4%) (P <0.001).
Conclusion: Our results revealed that IgM antibodies in the diagnosis of Covid -19, especially in the early stages of the disease have less diagnostic value compared to PCR. It seems that periodic follow-up of serological tests is necessary to know the production of appropriate antibody response in Covid-19 patients as well as in receiving the vaccine.


Page 1 from 1     

Persian site map - English site map - Created in 0.1 seconds with 28 queries by YEKTAWEB 4710